Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors

J Heart Lung Transplant. 2023 Mar;42(3):301-304. doi: 10.1016/j.healun.2022.12.016. Epub 2022 Dec 28.

Abstract

Shortage of organ donors is an ongoing limiting factor in lung transplantation (LT). Despite increasing prevalence of asymptomatic COVID-19 infection, positive COVID-19 testing from a potential donor remains a contraindication at many LT centers. In this report, we present the outcomes of LT utilizing an algorithm based on donor clinical presentation, and COVID-19 real-time reverse transcription polymerase chain reaction (RT-PCR) with cycle threshold (Ct) values evaluation. The Ct value threshold for organ acceptance was >35. A total of 8 COVID-positive donors were included. No donor-to-recipient transmissions of COVID-19 were observed. Short-term outcomes were comparable to those reported in pre-COVID literature. Survival-to-date is 100% with median POD of 161 days. Our findings support the safety and efficacy of utilizing our algorithm including Ct value threshold for selection of donors with incidental COVID-19 positive testing.

Keywords: COVID-19; donor selection; infection; lung transplant; survival.

MeSH terms

  • COVID-19 Testing
  • COVID-19* / diagnosis
  • Humans
  • Lung / diagnostic imaging
  • Polymerase Chain Reaction
  • Real-Time Polymerase Chain Reaction
  • Tissue Donors